Clinical trial
Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion and Pancreatic Fistula After Pancreatoduodenectomy
NCT02920567 is registered in ClinicalTrials.gov with Saint Vincent's Hospital, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion and Pancreatic Fistula After Pancreatoduodenectomy
- Lead sponsor
- Saint Vincent's Hospital, Korea
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- July 31, 2018
- Enrollment
- 282 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
periampullary tumors